Loading clinical trials...

UNKNOWNPhase 3NCT00526396

STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study

The purpose of this study is to compare the activity of fixed doses of cisplatin and etoposide with toxicity adjusted dosing of the same drugs in the first-line treatment of small cell lung cancer.

Lead sponsor: National Cancer Institute, Naples•12 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy

NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more

RECRUITING

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more

RECRUITINGPhase 1

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma, and more

RECRUITINGPhase 2

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

NCT07164170 · Non-Small Cell Lung Cancer

RECRUITINGNA

Hybrid Prehabilitation Before Thoracic Surgery

NCT06866717 · Non-Small Cell Lung Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 24, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment160

Start dateSep 2007

Last updatedMar 24, 2023

Condition

Small Cell Lung Cancer

Locations shown

Azienda Sanitaria S. Giuseppe Moscati

Monteforte Irpino, AV

Azienda Ospedaliera G. Rummo

Benevento, BN

Casa di Cura La Maddalena S.p.A., Dipartimento Oncologico

Palermo, PA

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions